Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
16.24
+0.55 (3.51%)
Apr 9, 2026, 11:59 AM EDT - Market open
Olema Pharmaceuticals Employees
Olema Pharmaceuticals had 131 employees as of December 31, 2025. The number of employees increased by 35 or 36.46% compared to the previous year.
Employees
131
Change (1Y)
35
Growth (1Y)
36.46%
Revenue / Employee
n/a
Profits / Employee
-$1,240,084
Market Cap
1.42B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 131 | 35 | 36.46% | 131 | 0 |
| Dec 31, 2024 | 96 | 22 | 29.73% | 96 | 0 |
| Dec 31, 2023 | 74 | -12 | -13.95% | 74 | 0 |
| Dec 31, 2022 | 86 | 12 | 16.22% | 83 | 3 |
| Dec 31, 2021 | 74 | 37 | 100.00% | 73 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Novavax | 749 |
| Immatics | 711 |
| Wave Life Sciences | 317 |
| Biohaven | 274 |
| Precigen | 160 |
| Monte Rosa Therapeutics | 150 |
| Maze Therapeutics | 141 |
OLMA News
- 6 days ago - Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 4 weeks ago - Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – OLMA - Business Wire
- 4 weeks ago - Why Is Olema Pharmaceuticals Stock Dropping On Monday? - Benzinga
- 2 months ago - Olema Oncology to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Olema Oncology Announces Departure of Chief Operating and Financial Officer - GlobeNewsWire
- 2 months ago - These 20 stocks are strong choices for momentum investors - Market Watch
- 3 months ago - Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire